SCHEMBL1709683

SCHEMBL1709683

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNC(=O)c2ccc(F)c(F)c2)n[nH]1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.59
TP53 P04637 2/20 0.37
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 2/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
OPRK1 P41145 3/20 0.34
OPRM1 P35372 2/20 0.34
POLB P06746 1/20 0.33
RORC P51449 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
S1PR3 Q99500 1/20 0.33
USP7 Q93009 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709674 0.92 GHSR (0.61) GHSRALDH1A1L3MBTL1OPRK1OPRM1
SCHEMBL1709549 0.91 GHSR (0.65) GHSRTP53ALDH1A1L3MBTL1GAA
SCHEMBL1709652 0.90 GHSR (0.57) GHSRTP53ALDH1A1L3MBTL1GAA
SCHEMBL1709547 0.87 GHSR (0.75) GHSRALDH1A1GAAOPRK1OPRM1
SCHEMBL10122103 0.86 GHSR (0.65) GHSRTP53ALDH1A1L3MBTL1GAA
SCHEMBL10121682 0.85 GHSR (0.69) GHSRL3MBTL1GAAOPRM1LMNA
SCHEMBL10121950 0.85 GHSR (0.64) GHSRALDH1A1GAAPOLBRORC
SCHEMBL10121676 0.85 GHSR (0.64) GHSRALDH1A1L3MBTL1GAAOPRK1
SCHEMBL10121683 0.84 GHSR (0.63) GHSRALDH1A1GAAOPRM1POLB
SCHEMBL1709677 0.84 GHSR (0.63) GHSRL3MBTL1GAAHPGDRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885TP53 4713/4885ALDH1A1 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.